Alto Neuroscience ANRO Common stock, capital shares reserved for future issuance
Common stock, capital shares reserved for future issuance at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's common stock, capital shares reserved for future issuance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's common stock, capital shares reserved for future issuance?
- Alto Neuroscience (ANRO) reported common stock, capital shares reserved for future issuance of $15.85M in Q1 2026.
- How has Alto Neuroscience's common stock, capital shares reserved for future issuance changed year-over-year?
- Alto Neuroscience's common stock, capital shares reserved for future issuance increased by 150.1% year-over-year, from $6.34M to $15.85M.
- What is the long-term trend for Alto Neuroscience's common stock, capital shares reserved for future issuance?
- Over 2 years (2023 to 2025), Alto Neuroscience's common stock, capital shares reserved for future issuance has grown at a -20.5% compound annual growth rate (CAGR), from $17.63M to $11.15M.